Pierre Gravier - Net Worth and Insider Trading
Pierre Gravier Net Worth
The estimated net worth of Pierre Gravier is at least $2 Million dollars as of 2024-12-01. Pierre Gravier is the CHIEF FINANCIAL OFFICER of PTC Therapeutics Inc and owns about 53,531 shares of PTC Therapeutics Inc (PTCT) stock worth over $2 Million. Details can be seen in Pierre Gravier's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pierre Gravier has not made any transactions after 2024-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pierre Gravier
Pierre Gravier Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pierre Gravier owns 1 companies in total, including PTC Therapeutics Inc (PTCT) .
Click here to see the complete history of Pierre Gravier’s form 4 insider trades.
Insider Ownership Summary of Pierre Gravier
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-07-16 | CHIEF FINANCIAL OFFICER |
Pierre Gravier Latest Holdings Summary
Pierre Gravier currently owns a total of 1 stock. Pierre Gravier owns 53,531 shares of PTC Therapeutics Inc (PTCT) as of July 16, 2024, with a value of $2 Million.
Latest Holdings of Pierre Gravier
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2024-07-16 | 53,531 | 43.88 | 2,348,940 |
Holding Weightings of Pierre Gravier
Pierre Gravier Form 4 Trading Tracker
According to the SEC Form 4 filings, Pierre Gravier has made a total of 2 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 2,269 shares on July 16, 2024, which brought Pierre Gravier around $77,191.
Insider Trading History of Pierre Gravier
- 1
Pierre Gravier Trading Performance
GuruFocus tracks the stock performance after each of Pierre Gravier's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pierre Gravier is 21.37%. GuruFocus also compares Pierre Gravier's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pierre Gravier within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pierre Gravier's insider trading performs compared to the benchmark.
Performance of Pierre Gravier
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.67 |  | | | | |
| Relative Return to S&P 500(%) | 1.65 | | | | | |
Pierre Gravier Ownership Network
Pierre Gravier Owned Company Details
What does PTC Therapeutics Inc do?
Who are the key executives at PTC Therapeutics Inc?
Pierre Gravier is the CHIEF FINANCIAL OFFICER of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include Chief Medical Officer Lee Scott Golden , Chief Development Officer Matthew B. Klein , and Chief Business Officer Eric Pauwels .
PTC Therapeutics Inc (PTCT) Insider Trades Summary
Over the past 18 months, Pierre Gravier made 2 insider transaction in PTC Therapeutics Inc (PTCT) with a net purchase of 5,431. Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,455 shares made by Matthew B. Klein , a net sale of 4,787 shares made by Eric Pauwels , and a net sale of 2,701 shares made by Lee Scott Golden .
In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 87,282 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 79,582 shares.
PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PTC Therapeutics Inc Insider Transactions
Pierre Gravier Mailing Address
Above is the net worth, insider trading, and ownership report for Pierre Gravier. You might contact Pierre Gravier via mailing address: C/o Ptc Therapeutics, Inc., 100 Corporate Court, South Plainfield Nj 07080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
